cis-4-Oxo-4-(phenylamino)but-2-enoic acid, 97.0%, 5g

5-Chloro-2-fluoro-3-(trifluoromethyl)benzoic acid, 98%, 1g

METHYL 3-IODO-1H-INDAZOLE-6-CARBOXYLATE, 95%, 250mg

1-Benzyl-4-cyanopyrazole, 95.0%, 1g

1-(2-Fluorophenyl)propan-1-ol, 95.0%, 1g

3,4-Bis(4-methoxybenzoyl)-1,2,5-oxadiazole 2-oxide, 97%, 1g

8-(tert-Butoxycarbonyl)-1-oxo-2,8-diazaspiro[4.5]decane-4-carboxylic acid, 98%, 500mg

3-nitroaniline, min 99%, pour synthèse, 500 g, emballage plastique.

(S)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity), 97%, 50mg

(6-bromo-2-methoxy-1-naphthyl)acetic acid, 95.0%, 2.5g

Filtres pour seringues CHROMAFIL® CA non stériles, 0,45 µm, 100 Pièce(s)

5-tert-Butyl 2-ethyl 6,7-dihydrofuro[3,2-c]pyridine-2,5(4H)-dicarboxylate, 95.0%, 500mg

3,5-Dimethoxyphenylacetonitrile, 96.0%, 1g